"Nowadays, Chinese pharmaceutical companies are capable of expanding their market worldwide, and Chinese medicine is capable of entering major Western markets, such as the U.S.," says Zhao Chao, president of Buchang Pharmaceuticals. "It's just a matter of how." Story
Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes
Wednesday, March 24 | 2pm ET / 11am PT
Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.
